A digital health technology company with exciting potential (Updated)
This digital health technology company developing solutions to assess brain health made significant progress in 2020 with new product developments and a big growth in its order book. With major pharmaceutical companies making progress with key therapies for Alzheimer's disease, a key area it supports, it would appear to have a very exciting future (IHT qualifying)
According to the World Health Organisation, disorders of the brain, such as Alzheimer’s disease, Schizophrenia, Parkinson’s, depression and mental illness, are the world’s primary cause of ill health, resulting in higher costs and more hospitalisations than any other disease group.
Early diagnosis of brain illnesses is desirable as it can help to reduce the costs associated with Alzheimer’s disease and dementia.
Cambridge Cognition Holdings (AIM: COG) is an AIM listed digital health technology company committed…
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
